Literature DB >> 12819168

Frequent wheeze at follow up of very preterm infants: which factors are predictive?

M Thomas1, A Greenough, A Johnson, E Limb, N Marlow, J L Peacock, S Calvert.   

Abstract

OBJECTIVE: To determine if chest radiograph appearance at 28 days or 36 weeks postmenstrual age (PMA) can predict recurrent wheeze or cough at follow up in prematurely born infants more effectively than readily available clinical data.
DESIGN: Chest radiographs of infants entered into the UKOS trial, who had had a chest radiograph at 28 days and 36 weeks PMA and completed six months of follow up, were assessed for the presence of fibrosis, interstitial shadows, cystic elements, and hyperinflation. At 6 months of corrected age, the occurrence and frequency of wheeze and cough since discharge were determined using a symptom questionnaire. PATIENTS: A total of 185 infants with a median gestational age of 26 (range 23-28) weeks.
RESULTS: Thirty seven infants wheezed more than once a week, compared with the rest of the cohort. These infants had significantly higher chest radiograph scores at 28 days (p = 0.020) and 36 weeks PMA (p = 0.005), with significantly higher scores at 28 days for fibrosis (p = 0.017) and at 36 weeks PMA for fibrosis (p = 0.001) and cystic elements (p = 0.0007). They had also been ventilated for longer (p = 0.013). Forty four infants coughed more than once a week; they did not differ significantly from the rest of the cohort. An abnormal chest radiograph score at 36 weeks PMA had the largest area under the receiver operator characteristic curve with regard to prediction of frequent wheeze.
CONCLUSION: An abnormal chest radiograph appearance at 36 weeks PMA predicts frequent wheeze at follow up and appears to be a better predictor than readily available clinical data.

Entities:  

Mesh:

Year:  2003        PMID: 12819168      PMCID: PMC1721561          DOI: 10.1136/fn.88.4.f329

Source DB:  PubMed          Journal:  Arch Dis Child Fetal Neonatal Ed        ISSN: 1359-2998            Impact factor:   5.747


  14 in total

1.  Relationship of symptoms to lung function abnormalities in preterm infants at follow-up.

Authors:  B Yuksel; A Greenough
Journal:  Pediatr Pulmonol       Date:  1991

2.  The meaning and use of the area under a receiver operating characteristic (ROC) curve.

Authors:  J A Hanley; B J McNeil
Journal:  Radiology       Date:  1982-04       Impact factor: 11.105

3.  Radiographic-pathologic correlation in bronchopulmonary dysplasia.

Authors:  D K Edwards; T V Colby; W H Northway
Journal:  J Pediatr       Date:  1979-11       Impact factor: 4.406

4.  A simple chest radiograph score to predict chronic lung disease in prematurely born infants.

Authors:  A Greenough; V Kavvadia; A H Johnson; S Calvert; J Peacock; J Karani
Journal:  Br J Radiol       Date:  1999-06       Impact factor: 3.039

5.  The chest radiograph appearances of very premature infants at 36 weeks post-conceptional age.

Authors:  A Greenough; G Dimitriou; A H Johnson; S Calvert; J Peacock; J Karani
Journal:  Br J Radiol       Date:  2000-04       Impact factor: 3.039

6.  Potential of early chest roentgen examination in ventilator treated newborn infants to predict future lung function and disease.

Authors:  W Mortensson; B Andréasson; M Lindroth; N Svenningsen; B Jonson
Journal:  Pediatr Radiol       Date:  1989

Review 7.  Respiratory morbidity in preschool children born prematurely. Relationship to adverse neonatal events.

Authors:  A Greenough; F J Giffin; B Yüksel
Journal:  Acta Paediatr       Date:  1996-07       Impact factor: 2.299

8.  High-frequency oscillatory ventilation for the prevention of chronic lung disease of prematurity.

Authors:  Alice H Johnson; Janet L Peacock; Anne Greenough; Neil Marlow; Elizabeth S Limb; Louise Marston; Sandra A Calvert
Journal:  N Engl J Med       Date:  2002-08-29       Impact factor: 91.245

9.  Chest radiograph scoring system for use in pre-term infants.

Authors:  B Yuksel; A Greenough; J Karani; A Page
Journal:  Br J Radiol       Date:  1991-11       Impact factor: 3.039

10.  Ipratropium bromide for symptomatic preterm infants.

Authors:  B Yuksel; A Greenough
Journal:  Eur J Pediatr       Date:  1991-10       Impact factor: 3.183

View more
  5 in total

1.  Nebulized furosemide in the treatment of bronchopulmonary dysplasia in preterm infants.

Authors:  Jasmine Sahni; Stephanie J Phelps
Journal:  J Pediatr Pharmacol Ther       Date:  2011-01

Review 2.  Update on the diagnosis and management of bronchopulmonary dysplasia/chronic lung disease of infancy: what the radiologist should know.

Authors:  Richard B Parad
Journal:  Pediatr Radiol       Date:  2012-03-06

3.  Radiological outcome of very prematurely born infants randomised to high frequency oscillatory or conventional ventilation.

Authors:  Anne Greenough; Elizabeth Limb; Neil Marlow; Janet L Peacock; Sandra Calvert
Journal:  Eur J Pediatr       Date:  2004-08-12       Impact factor: 3.183

4.  Protocol for the smoking, nicotine and pregnancy (SNAP) trial: double-blind, placebo-randomised, controlled trial of nicotine replacement therapy in pregnancy.

Authors:  Tim Coleman; Jim Thornton; John Britton; Sarah Lewis; Kim Watts; Michael W H Coughtrie; Clare Mannion; Neil Marlow; Christine Godfrey
Journal:  BMC Health Serv Res       Date:  2007-01-03       Impact factor: 2.655

5.  Respiratory outcomes of the surfactant positive pressure and oximetry randomized trial (SUPPORT).

Authors:  Timothy P Stevens; Neil N Finer; Waldemar A Carlo; Peter G Szilagyi; Dale L Phelps; Michele C Walsh; Marie G Gantz; Abbot R Laptook; Bradley A Yoder; Roger G Faix; Jamie E Newman; Abhik Das; Barbara T Do; Kurt Schibler; Wade Rich; Nancy S Newman; Richard A Ehrenkranz; Myriam Peralta-Carcelen; Betty R Vohr; Deanne E Wilson-Costello; Kimberly Yolton; Roy J Heyne; Patricia W Evans; Yvonne E Vaucher; Ira Adams-Chapman; Elisabeth C McGowan; Anna Bodnar; Athina Pappas; Susan R Hintz; Michael J Acarregui; Janell Fuller; Ricki F Goldstein; Charles R Bauer; T Michael O'Shea; Gary J Myers; Rosemary D Higgins
Journal:  J Pediatr       Date:  2014-04-13       Impact factor: 4.406

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.